This study tests a new treatment approach for people with early-stage triple negative breast cancer whose tumors have a high number of immune cells, called tum…

Triple Negative Breast Cancer (TNBC)Elevated Tumor-Infiltrating Lymphocytes

~Estimated

~$10 – $6,250

Medical University of South CarolinaNCT07743190

Phase 1

Tumor Infiltrating Lymphocytes in Pediatric Malignant Solid Tumors: A Prospective Biobanking Study and Phase I Clinical Trial

Part One of this study will determine the feasibility of creating Tumor-Infiltrating Lymphocyte (TIL) product prospectively from high-risk pediatric solid tumo…

Lymphocytes

~Estimated

~$10 – $6,250

H. Lee Moffitt Cancer Center and Research InstituteNCT06047977